Summary
The essential trace element selenium has recently attracted attention because of its potentialities in the maintenance of human health. Selenium forms part of the active site of the peroxide-destroying enzyme glutathione peroxidase, and it also has other functions, for example in biotransformation, detoxification and the immune response. Functional and clinical consequences of selenium deficiency states have been described, and the selenium requirement, which is influenced by the usual selenium exposure, has been discussed. Wide variations have been found in selenium status in different parts of the world, and populations or groups of patients exposed to marginal deficiency are more numerous than was previously thought.
Current research activities in the field of human medicine and nutrition are devoted to the possibilities of using selenium for the prevention or treatment of degenerative or free radical diseases such as neurological disorders, inflammatory diseases or cancer. Pharmacological selenium doses are also recommended as an adjuvant in some treatments.
Similar content being viewed by others
References
Alfthan, G., Longitudinal study on the selenium status of healthy adults in Finland during 1975–1984. Nutr. Res. (1987).
Arnaud, J., Chappuis, P., Clavel, J. P., Bienvenu, F., and Favier, A., Méthodes de dosage du selenium dans les milieux biologiques. Annls Biol. clin.44 (1986) 459–69.
Arnaud, J., Favier, A., Zarski, J. P., Rachail, M., Labadie, H., and Beaugrand, M., Serum selenium in alcoholic disease, in: Selenium in Medicine and Biology, pp. 273–276. Eds. J. Nève and A. Favier. W. de Gruyter, Berlin/New York 1988.
Aro, A., Alfthan, G., Soimakallio, S., and Voutilainen, E., Se concentrations in serum and angiographically defined coronary artery disease are uncorrelated. Clin. Chem.32 (1986) 911–912.
Arvilomni, H., Poikonen, K., Jokinen, I., Muukonen, O., Rasanen, L., Foreman, J., and Huttunen, J. K., Selenium and immune functions in humans. Infect. Immun.41 (1983) 185–189.
Aviado, D. M., Drimal, J., Watenabe, T., and Lish, P. M., Cardiac effects of sodium selenite. Cardiology60 (1975) 113–120.
Aziz, G. Z., Klesius, P. H., and Frandsen, J. C., Effects of selenium on polymorphonuclear leukocyte function in goats. Am. J. vet. Res.45 (1984) 1715–1718.
Backman, E., Nylander, E., Johansson, I., Henriksson, K. G., and Tagesson, C., Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function. Acta neurol. scand.78 (1988) 429–435.
Baker, S. S., Lerman, R., Krey, S., Crocker, K., Hirsh, E., and Cohen, H., Selenium deficiency with total parenteral nutrition: reversal of biochemical and functional abnormalities by selenium supplementation. Am. J. clin. Nutr.38 (1983) 769–774.
Baptista, R. J., Bistrian, B. R., Blackburn, G., Miller, D. G., Champagne, C. D., and Buchanan, L., Utilizing selenous acid to reverse selenium deficiency in total parenteral nutrition patients. Am. J. clin. Nutr.39 (1984) 816–820.
Becket, G. J., MacDougall, D. A., Nicol, F., and Arthur, J. R., Inhibition of type I and type II iodothyronine deiodinase activity in rat liver, kidney and brain produced by selenium deficiency. Biochem. J.259 (1988) 887–892.
Behne, D., Von Berswordt Wallrabe, R., Elger, W., Hube, G., and Wolters, W., Effects of pregnancy and lactation on the serum selenium content of rats. Experientia34 (1978) 270–271.
Behne, D., Selenium homeostasis, in: Selenium in Medicine and Biology, pp. 83–91. Eds J. Nève and A. Favier. W. de Gruyter, Berlin/New York 1989.
Bleau, G., Lemarbre, J., Faucher, G., Roberts, K., and Chapdelaine, A., Semen selenium and human fertility. Fert. Steril.42 (1984) 890–894.
Bryant, R. W., Simon, T. C., and Bailey, J. M., Altered lipoxygenase metabolism and decreased glutathione peroxydase activity in platelets from selenium deficient rats. Biochem. biophys. Res. Commun.92 (1980) 268–276.
Bunker, V. W., Lawson, M. S., Stanfield, M. F., and Clayton, B. E., Selenium balance studies in apparently healthy and house bound elderly people eating self selected diets. Br. J. Nutr.59 (1988) 171–180.
Butler, J. A., Whanger, P. D., and Tripp, M. J., Blood selenium and glutathione peroxidase activity in pregnant women: comparative assays in primates and other animals. Am. J. clin. Nutr.36 (1982) 15–23.
Chance, B., Sies, H., and Boveris, A., Hydroperoxide metabolism in mammalian organs. Physiol. Rev.59 (1979) 527–605.
Chappuis, P., Paolaggi, F., Rousselet, F., and Faugeron, C., Problems and new trends in selenium determination in biological materials, in: Selenium in Medicine and Biology, pp. 159–170. Eds. J. Nève and A. Favier. W. de Gruyter, Berlin/New York 1989.
Cohen, H. J., Brown, M., Lyons, J., Avissar, N., Hamilton, D., and Liegey, P., Clinical, physiological and biochemical consequences of human selenium deficiency, in: Essential and Toxic Trace Elements in Human Health and Disease, pp. 201–210. Alan R. Liss, New York 1988.
Collipp, P. J., and Chen, S. Y., Cardiomyopathy and selenium deficiency in a two-year-old girl. New Engl. J. Med.304 (1981) 1210–1212.
Combs, G. F., and Combs, S. B., Selenium effects on drug and foreign compounds toxicity. Pharmac. Ther.33 (1987) 303–315.
Committee on Dietary Allowances, Food and Nutrition Board, National Research Council. Recommended dietary allowances, 9th edn. National Academy Press, Washington DC 1980.
Diplock, A. T., Watkins, W. J., and Heurson, M., Selenium and heavy metals. Annls clin. Res.18 (1986) 55–60.
Doni, M. G., Bonaccorso, G., and Piva, E., High glutathione peroxidase and prostacyclin like activity generation in rat aorta. Haemostasis13 (1983) 248–254.
Dworkin, B. M., Rosenthal, W. S., Jankowski, R. H., Gordon, G. G., and Haldea, D., Low blood selenium levels in alcoholics with and without advanced liver disease: correlations with clinical and nutritional status. Dig. Dis. Sci.30 (1985) 838–844.
Favier, A., Arnaud, J., and Piedimonte, A., Données actuelles sur la biochimie des oligoéléments. III le sélénium. Lyon Pharmaceutique35 (1984) 343–353.
Fondu, P., Hariga Muller, C., Mozes, N., Nève, J., Van Steirteghem, A., and Mandelbaum, L., Protein energy malnutrition and anemia in Kivu. Am. J. clin. Nutr.31 (1978) 46–56.
Gissel Nielsen, G., Selenium fertilizers and foliar application. Danish experiments. Annls clin. Res.18 (1986) 61–64.
Gyones, P., Golstein, J., Nsombola, B., Vis, H., and Dumont, J. E., Selenium deficiency as a possible factor in the pathogenesis of myxoedematous endemic cretinism. Acta endocr.114 (1987) 497–502.
Guidi, G., Schiavon, R., Biasioli, A., and Perona, G., The enzyme glutathione peroxidase in arachidonic acid metabolism of human platelets. J. Lab. clin. Med.104 (1984) 574–582.
Guidi, G. C., Bellisola, G., Schiavon, R., Galassini, S., Liu, N. Q., and Moschini, G., Effects of increasing dietary selenium intake in humans. Preliminary results of a longitudinal study, in: Trace Element Analytical Chemistry in Medicine and Biology, vol. 5, pp. 377–383. Eds P. Brätter and P. Schramel. W. de Gruyter, Berlin/New York 1988.
Hotz, P., Hoet, P., and Lauwerijs, R., Peroxydation lipidique en pathologie humaine. Path. Biol.35 (1987) 1067–1073.
Huttunen, J. K., and Virtamo, J., Trace elements and cardiovascular disease, in: Diet and Prevention of Coronary Heart Disease and Cancer, pp. 163–173. Ed. B. Hallgren. Raven Press, New York 1986.
Ip, C., and Hayes, C., Tissue selenium levels in selenium supplemented rats and their relevance in mammary cancer protection. Carcinogenesis10 (1985) 921–925.
Johansson, U., Johnson, F., Joelsson, B., Berglund, M., and Akesson, B., Selenium status in patients with liver cirrhosis and alcoholism. Br. J. Nutr.55 (1986) 227–233.
Kien, C. L., and Ganther, H. E., Manifestations of chronic selenium deficiency in a child receiving total parenteral nutrition. Am. J. clin. Nutr.37 (1983) 319–328.
Kirimidjian Schumacker, L., and Statzky, G., Selenium and immune responses. Envir. Res.42 (1987) 277–303.
Koivistoinen, P., and Huttunen, J. K., Selenium in food and nutrition in Finland. An overview on research and action. Annls clin. Res.18 (1986) 13–17.
Levander, O. A., Selenium, in: Trace Elements in Human and Animal Nutrition, vol. 2, pp. 209–280. Ed. W. Mertz. Academic Press, Orlando 1986.
Levander, O. A., A global view of human selenium nutrition. A. Rev. Nutr.7 (1987) 227–250.
Levander, O. A., Alfthan, G., Arvilomni, H., Gref, C., Huttunen, J. K., Kataja, M., Koivistoinen, P., and Pikkarainen, J., Bioavailability of selenium to Finnish men as assessed by platelet glutathione peroxidase activity and other blood parameters. Am. J. clin. Nutr.37 (1983) 889–897.
Levander, O. A., and Morris, V. C., Dietary selenium levels needed to maintain balance in North American adults consuming self selected diets. Am. J. clin. Nutr.39 (1984) 809–815.
Lombeck, I., and Menzel, H., Selenium in neonates and children, in: Selenium in Medicine and Biology, pp. 197–206. Eds J. Nève and A. Favier. W. de Gruyter, Berlin 1988.
Luo, X., Wei, H., and Yang, C., Bioavailability of selenium to residents in low selenium area of China. Am. J. clin. Nutr.42 (1985) 439–448.
Luo, X., Wei, H., Yang, C., Xing, J., Qiao, C., Feng, Y., Liu, J., Liu, Z., Wu, Q., Liu, Y., Stoecker, B. Spallholz, J. E., and Yang, P., Selenium intake and metabolic balance of 10 men from a low selenium area in China. Am. J. clin. Nutr.42 (1985) 31–37.
Luoma, P. V., Sotaniemi, E. A., Korpela, H., and Kumpulainen, J., Serum selenium, glutathione peroxidase activity and high density lipoprotein cholesterol. Effect of selenium supplementation. Res. Commun. chem. Path. Pharmac.46 (1984) 469–472.
Magos, L., Clarkson, T., Sparrow, S., and Hudson, A. R., Comparison of the protection given by selenite selenomethionine and biological selenium against the renotoxicity of mercury. Archs Toxic.60 (1987) 422–426.
Masukawa, T., Goto, J., and Iwata, H., Impaired metabolism of arachidonate in selenium deficient animals. Experientia39 (1983) 405–406.
Miettinen, T. A., Alfthan, G., Huttunen, J. K., Pikkarainen, J., Naukkarinen, V., Mattila, S., and Kumlin, T., Serum selenium concentration related to myocardial infarction and fatty acid content of serum lipids. Br. med. J.287 (1983) 517–519.
Moore, J. A., Noiva, R., and Wells, I. C., Selenium concentration in plasma of patients with arteriographically defined coronary atherosclerosis. Clin. Chem.30 (1984) 1171–1173.
Nève, J., Vertongen, F., Cauchie, P., Gnat, D., and Molle, L., Selenium and glutathione peroxidase in plasma and erythrocytes of Down's syndrome (trisomy 21) patients. J. ment. Defic. Res.28 (1984) 261–268.
Nève, J., Vertongen, F., and Molle, L., Relationship between selenium and glutathione peroxidase in blood of normal and selenium deficient subjects, in: Industrial Uses of Selenium and Tellurium, pp. 537–547. Edited and printed by the Selenium Tellurium Development Association, 1984.
Nève, J., Vertongen, F., Thonnart, N., and Carpentier, Y. A., Assessment of selenium status in patients receiving long-term total parenteral nutrition, in: Trace Element Analytical Chemistry in Medicine and Biology, pp. 139–149. Eds P. Brätter and P. Schramel. W. de Gruyter, Berlin/New York 1984.
Nève, J., Vertongen, F., and Molle, L., Selenium deficiency. Clin. Endocr. Metab.14 (1985) 629–656.
Nève, J., Vertongen, F., and Capel, P., Selenium supplementation in helathy Belgian adults: response in platelet glutathione peroxidase activity and other blood parameters. Am. J. clin. Nutr.48 (1987) 139–143.
Nève, J., Henry, M., Peretz, A., and Mareschi, J. P., L'importance nutritionnelle du sélénium. Cah. Diet. Nutr.22 (1987) 145–162.
Nève, J., Biological parameters for assessing selenium status, in: Selenium in Medicine and Biology, pp. 137–148. Eds J. Nève and A. Favier. W. de Gruyter, Berlin 1988.
Nève, J., Biological functions of selenium, in: Selenium in Medicine and Biology, pp. 97–112. Eds J. Nève and A. Favier. W. de Gruyter, Berlin 1988.
Nève, J., Vertongen, F., Peretz, A., and Carpentier, Y. A., Valeurs usuelles du sélénium et de la glutathion peroxydase dans une population belge. Annls Biol. clin.47 (1989) 133–148.
Nève, J., Vertongen, F., Peretz, A., and Van Erum, S., Selenium status in healthy Belgian adults: assessment of adequacy by various biochemical indices and response to supplementation, in: Trace Element Analytical Chemistry in Medicine and Biology, vol. 5, pp. 371–376. Eds P. Brätter and P. Schramel. W. de Gruyter, Berlin/New York 1989.
Nève, J., Chamart, S., Van Erum, S., Vertongen, F., and Dramaix, M., Selenium status in humans as investigated by the effects of supplementation with Se enriched yeast tablets, in: Selenium in Medicine and Biology, pp. 315–320. Eds J. Nève and A. Favier. W. de Gruyter, Berlin/New York 1989.
Nève, J., and Carpentier, Y. A., Laboratory methods for assessment of selenium status, in: Nutrition in Clinical Practice, pp. 273–286. Eds W. Hartig, G. Dietze and R. Weiner. Karger, Basel 1989.
Nève, J., Sélénium et vieillissement. J. Med. esthet. Chirurg. dermat.26 (1989) 185–190.
Nordberg, G. F., Factors influencing metabolism and toxicity of metals: a consensus report. Envir. Hlth Perspect.25 (1978) 3–41.
Ohrndahl, G., Sellden, U., Hallin, S., Wettergvist, H., Rindby, A., and Selin, E., Myotonic dystrophy treated with selenium and vitamin E. Acta med. scand.219 (1986) 407–414.
Oster, O., Prellwitz, W., Kasper, W., and Meinertz, T., Congestive cardiomyopathy and the selenium content of serum. Clin. chim. Acta128 (1983) 125–132.
Paglia, D. E., and Valentine, V. W., Studies on the qualitative and quantitative characterization of erythrocyte glutathione peroxidase. J. Lab. clin. Med.70 (1970) 158–178.
Peretz, A., Nève, J., Famaey, J. P., and Molle, L., Oligo éléments essentiels et affections rhumatismales. J. Pharm. Belg.42 (1987) 395–403.
Peretz, A., Selenium in inflammation and immunity, in: Selenium in Medicine and Biology, pp. 235–246. Eds J. Nève and A. Favier. W. de Gruyter, Berlin 1988.
Peretz, A., Nève, J., Vertongen, F., Famaey, J. P., and Molle, L., Selenium status in relation to clinical parameters and drug treatment in rheumatoid arthritis. J. Rheumat.14 (1987) 1103–1107.
Perona, C., Guidi, G. C., Piga, A., Cellerino, R., Menna, R., and Zatti, M. In vivo and in vitro variations of human erythrocyte glutathione peroxidase activity as a result of cells ageing, selenium availability and peroxide activation. Br. J. Haemat.39 (1978) 399–408.
Pineau, A., Selenium toxicology, in: Selenium in Medicine and Biology, pp. 345–349. Eds J. Nève and A. Favier. W. de Gruyter, Berlin/New York 1989.
Pryor, W. A., The free radical theory of aging revisited: A critique and a suggested disease specific theory, in: Modern Biological Theories of Aging, pp. 89–112. Eds H. R. Warner et al. Raven Press, New York 1987.
Richard, M. J., Arnaud, J., Koukay, N., Favier, A., Jurkovitz, C., Dechelette, E., Hachache, T., Meftahi, H., Foret, M., and Laporte, F., Lipid peroxidation, relationship with selenium and glutathione peroxidase activities in patients with chronic renal failure, in: Selenium in Medicine and Biology, pp. 283–288. Eds J. Nève and A. Favier. W. de Gruyter, Berlin/New York 1989.
Richard, M. J., Arnaud, J., Favier, A., Aguilaniu, B., Gout, J. P., and Decoux, G., Selenium and oxidant injury in cystic fibrosis children, in: Selenium in Medicine and Biology, pp. 219–223. Eds J. Nève and A. Favier. W. de Gruyter, Berlin/New York 1989.
Robinson, J. R., Robinson, M. F., Levander, O. A., and Thomson, C. D., Urinary excretion of selenium by New Zealand and North American human subjects on differing intakes. Am. J. clin. Nutr.41 (1985) 1023–1031.
Rotruck, J. T., Pope, A. L., and Ganther, H. E., Selenium: biochemical role as a component of glutathione peroxidase. Science179 (1973) 588–590.
Sakurai, H., and Tsuchiya, K., A tentative recommendation for maximum daily intake of selenium. Envir. Physiol. Biochem.5 (1975) 588–590.
Salonen, J. T., Selenium and human cancer. Annls. clin. Res.18 (1986) 18–21.
Salonen, J. T., and Huttunen, J. K., Selenium in cardiovascular diseases. Annls clin. Res.18 (1986) 30–35.
Salonen, J. T., Selenium in ischemic heart disease. Int. J. Epidem.16 (1987) 323–328.
Salonen, J. T., Alfthan, G., Pikkarainen, J., Huttunen, J. K., and Puska, P., Association between cardiovascular death and myocardial infarction and serum selenium in a matched pair longitudinal study. Lancet (1982) 175–179.
Salonen, J. T., Salonen, R., Pentila, I., Herranen, J., Tauhiainen, M., Kantola, S., Lappetelaïnen, R., Mäenpäa, P., Alfthan, G., and Puska, P., Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am. J. Cardiol.56 (1985) 226–231.
Santivuori, P., Experience over 17 years with antioxidant treatment in Spielmeyer Sjörgen Disease. Am. J. med. Genet.5 (1988) 265–274.
Satoh, M., Naganuma, A., and Imura, N., Optimum schedule of selenium administration to reduce lethal and renal toxicities of cis diaminedichlorplatinium in mice. J. Pharmac. Dyn.12 (1989) 246–253.
Schwarz, K., and Flotz, C., Selenium as an integral part of factor 3 against necrotic dietary liver degeneration. J. Am. chem. Soc.79 (1957) 3292–3293.
Schrauzer, G. N., Selenium and cancer, in: Selenium in Medicine and Biology, pp. 251–261. Eds J. Nève and A. Favier. W. de Gruyter, Berlin/New York 1988.
Schrauzer, G. N., Selenium in nutritional cancer prophylaxis: an update, in: Vitamins, Nutrition and Cancer, pp. 240–250. Karger, Basel 1984.
Sinet, P. M., and Nève, J., Blood copper, zinc and selenium in Down's syndrome, in: Metal Ions in Neurology and Psychiatry, p. 35–48. Alan R. Liss, New York 1985.
Sinet, P. M., Lejeune, J., and Jerome, H., Trisomy 21 (Down's syndrome), glutathione peroxidase, hexose monophosphate shunt and IQ. Life Sci.24 (1979) 29–34.
Spallholz, J. E., Anti inflammatory immunologic and carcinostatic attributes of selenium in experimental animals. Adv. exp. Med. Biol.135 (1981) 43–62.
Stadman, T. C., Specific occurrence of selenium in enzymes and amino acid t-RNAS. FASEB J.1 (1987) 375–379.
Staed, N. W., Leonard, S., and Caroll, R., Effect of selenium supplementation on selenium balance in the dependent elderly. Am. J. med. Sci.290 (1985) 228–233.
Thomson, C. D., Ong, L. K., and Robinson, M. F., Effects of supplementation with high selenium wheat bread on selenium, glutathione peroxidase and related enzymes in blood components of New Zealand residents. Am. J. clin. Nutr.41 (1985) 1015–1022.
Thorling, E. B., Overvad, K., and Geboers, J., selenium status in Europe. Human data. A multicenter study. Annls clin. Res.18 (1986) 3–9.
Tolonen, M., Sarna, S., Halme, M., Tuommen, S., Westermarck, T., Nordberg, X., Keikonen, M., and Schrijver, J., Antioxidant supplementation decreases TBA reactants in serum of elderly. Biol. Trace Elem. Res.17 (1988) 221–228.
Tolonen, M., Halme, M., and Sarna, S., Vitamin E and selenium supplementation in geriatric patients. Biol. Trace Elem. Res.7 (1985) 161–168.
Tolonen, M., Sarna, S., Keinonen, M., Halme, M., and Nordberg, U. R., Antioxidant supplementation reduces lipid peroxides in the elderly. A randomized double blind one year study, in: Selenium in Medicine and Biology, pp. 329–332. Eds J. Nève and A. Favier. W. de Gruyter, Berlin/New York 1989.
Toivanen, J. L., Effects of selenium, vitamin E and vitamin C on human prostacyclin and thromboxan synthesis in vitro. Prostag. Leukotrienes Med.26 (1987) 265–275.
Urban, I., and Jarstrand, C., Selenium effects on human neutrophilic granulocyte function in vitro. Immunopharmacology12 (1986) 167–172.
Van Caillie Bertrand, M., Degenhart, H. J., and Fernandes, J., Influence of age on the selenium status in Belgium and The Netherlands. Pediatr. Res.20 (1986) 574–580.
Van Rij, A. M., Thomson, C. D., McKenzie, J. M., and Robinson, M. F., Selenium deficiency in total parenteral nutrition. Am. J. clin. Nutr.32 (1979) 2086–2085.
Van Rij, A. M., Wade, C., Kirk, I., Thomson, C., and Robinson, M. F., Altered platelet lipoxygenase activity in patients with low selenium. Clin. Sci.73 (1987) 525–529.
Varo, P., Alfthan, G., Ekholm, P., Aro, H., and Koivistooinen, P., Selenium intake and serum selenium in Finland: effects of soil fertilization with selenium. Am. J. clin. Nutr.48 (1988) 324–329.
Vernie, L. N., Selenium in carcinogenesis. Biochim. biophys. Acta783 (1984) 203–217.
Vinton, N. E., Dahlstrom, K. A., Strobel, C. T., and Ament, M. E., Macrocytosis and pseudoalbinism: manifestations of selenium deficiency. J. Pediatr.111 (1987) 711–717.
Wendel, A., Otter, R., Alterations in the intermediary metabolism of selenium deficient mice. Biochim. biophys. Acta925 (1987) 94–100.
Yang, G., Wang, S., Zhou, R., and Sun, S., Endemic selenium intoxication of humans in China. Am. J. clin. Nutr.37 (1983) 872–881.
Yang, G., Chen, J., Wen, Z., and Ge, K., The role of selenium in Keshan disease, in: Advances in Nutritional Research, pp. 203–231. Ed. H. H. Drapper. Plenum Press, New York 1984.
Yu, S. Y., Li, W., Zhu, Y., Yu, W., and Hou, C., Chemoprevention trial of human hepatitis with selenium supplementation in China. Biol. Trace Elem. Res.20 (1989) 15–22.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nève, J. Physiological and nutritional importance of selenium. Experientia 47, 187–193 (1991). https://doi.org/10.1007/BF01945424
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01945424